News and Trends 9 Dec 2022New targeted drug shows benefit against breast cancer in first phase III trial A new type of targeted medicine has shown ‘remarkable’ benefits for patients with advanced breast cancer in a major phase… December 9, 2022 - 7 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 4 Aug 2022New breast cancer treatment receives funding Researchers at Queen’s University Belfast in Northern Ireland have received funding from Breast Cancer Now to search for new treatments… August 4, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 9 Feb 2023Cleveland Clinic breast cancer vaccine study moves forward Researchers from global health system Cleveland Clinic have launched the next step in their novel study of a vaccine aimed… February 9, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 16 Sep 2022Ghana first to benefit from Roche partnership with Jhpiego to improve cervical and breast cancer outcomes for women Roche has signed a memorandum of understanding (MoU) with the Johns Hopkins Program for International Education in Gynecology and Obstetrics… September 16, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 2 Sep 2022Ibex reports positive outcomes for AI-supported diagnosis of breast cancer Ibex Medical Analytics have just announced positive outcomes for its Galen Breast solution in diagnosing multiple cancer types and further… September 2, 2022 - 4 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 26 Jan 2023Ibex to collaborate with AstraZeneca and Daiichi Sankyo on AI breast cancer product Ibex Medical Analytics has announced an agreement with AstraZeneca and Daiichi Sankyo, for the development, clinical validation and early adoption… January 26, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 28 Jun 2022Breast cancer drug recommended for approval A cancer drug from AstraZeneca and Daiichi Sankyo called Enhertu, that reduces the risk of disease progression or even death… June 28, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 24 Jan 2018No Entry! This Protein Could Stop Breast Cancer from Escaping to the Rest of the Body Spanish scientists have found genes that maintain breast cancer cells in a dormant state, which could be manipulated to control… January 24, 2018 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 12 Sep 2022Reveal Genomics reveals more HER2DX breast cancer validation data Reveal Genomics, S.L. says it has received more validation of HER2DX, the world's first specialized genomic test for HER2+ breast… September 12, 2022 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 26 Jul 2022New AstraZeneca and Daiichi Sankyo breast cancer drug accepted by FDA A drug candidate for unresectable or metastatic breast cancer has been accepted by the US Food and Drug Administration (FDA).… July 26, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 26 May 2016Qiagen partners up for Novel Diagnostic against Breast Cancer Qiagen is partnering up with Therawis to develop a diagnostic test to predict how effective an aggressive chemotherapy will be… May 26, 2016 - 2 minutesmins - By Denise Neves Gameiro Share WhatsApp Twitter Linkedin Email
News and Trends 31 Jan 2023Stemline Therapeutics’ breast cancer treatment approved The Menarini Group, an Italian pharmaceutical and diagnostics company, says that the U.S. Food and Drug Administration (FDA) has approved… January 31, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 6 Feb 2019Combo of Immunotherapy and Diabetes Drug Could Beat Breast Cancer A Finnish research group has combined two cancer drugs with the diabetes drug metformin, making mice with breast cancer survive… February 6, 2019 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 21 Jun 2022New data demonstrates clinical potential of Inivata’s RaDaR technology for breast cancer Data supporting the detection of minimal residual disease (MRD) has highlighted potential to provide an early predictor of tumor recurrence… June 21, 2022 - 3 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 4 May 2023Osteoporosis drug helps T cells fight aggressive breast cancer Researchers in Germany have discovered a mechanism by which cancer cells escape the immune system - and how to reverse… May 4, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 15 Jan 2018The FDA Gives AstraZeneca’s Breast Cancer Drug the Go-Ahead The UK big pharma company's Lynparza will be for women with advanced breast cancer that is specifically caused by mutations… January 15, 2018 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 19 Oct 2017Personalized Breast Cancer Treatment Coming Soon with Help from Spanish Biotech Inbiomotion has published the results of a Phase III study looking at its MAFTest to personalized approaches to the disease.… October 19, 2017 - 3 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email
News and Trends 21 Mar 2018A Personalized Genetic Test for Breast Cancer Arrives in Europe Agendia will launch a next-generation sequencing test in the EU to determine the chances of metastasis in breast cancer patients. … March 21, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 25 May 2017Resilient Tumor Cells Drive Breast Cancer Relapse in Mice Tumor cells that survive chemotherapy and drive breast cancer relapse may provide drug targets for potential treatments to reduce the… May 25, 2017 - 3 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
News and Trends 13 Feb 2018Erytech’s ‘Armed’ Red Blood Cells Will be Tested Against Triple Negative Breast Cancer Erytech will test its Graspa technology for the treatment of a second solid tumor indication, breast cancer, following its success… February 13, 2018 - 2 minutesmins - By Alex Dale Share WhatsApp Twitter Linkedin Email